You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR NATESTO


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for NATESTO

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02611154 ↗ Intranasal Delivery of Testosterone and Its Effect on Doping Markers Completed Partnership for Clean Competition Phase 4 2015-11-18 Hypothesis: Intranasal administration of exogenous testosterone results in a characteristic profile during anti-doping testing, which is different than the profile seen when testosterone is administered into muscle, on skin or under the tongue. Objective: The investigators aim to characterize the unique steroid doping profile following administration of intranasal testosterone to healthy, active volunteer subjects.
NCT02611154 ↗ Intranasal Delivery of Testosterone and Its Effect on Doping Markers Completed Sports Medicine Research and Testing Laboratory Phase 4 2015-11-18 Hypothesis: Intranasal administration of exogenous testosterone results in a characteristic profile during anti-doping testing, which is different than the profile seen when testosterone is administered into muscle, on skin or under the tongue. Objective: The investigators aim to characterize the unique steroid doping profile following administration of intranasal testosterone to healthy, active volunteer subjects.
NCT02611154 ↗ Intranasal Delivery of Testosterone and Its Effect on Doping Markers Completed University of Utah Phase 4 2015-11-18 Hypothesis: Intranasal administration of exogenous testosterone results in a characteristic profile during anti-doping testing, which is different than the profile seen when testosterone is administered into muscle, on skin or under the tongue. Objective: The investigators aim to characterize the unique steroid doping profile following administration of intranasal testosterone to healthy, active volunteer subjects.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for NATESTO

Condition Name

Condition Name for NATESTO
Intervention Trials
Hypogonadism, Male 4
Hypogonadism 2
Aqueous Tear Deficiency 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for NATESTO
Intervention Trials
Hypogonadism 6
Eunuchism 4
Meibomian Gland Dysfunction 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for NATESTO

Trials by Country

Trials by Country for NATESTO
Location Trials
United States 20
Canada 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for NATESTO
Location Trials
Florida 3
California 2
Utah 2
Indiana 1
Colorado 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for NATESTO

Clinical Trial Phase

Clinical Trial Phase for NATESTO
Clinical Trial Phase Trials
Phase 4 7
Phase 2 1
Early Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for NATESTO
Clinical Trial Phase Trials
Recruiting 4
Completed 3
Not yet recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for NATESTO

Sponsor Name

Sponsor Name for NATESTO
Sponsor Trials
Acerus Pharmaceuticals Corporation 5
University of Utah 2
University of Miami 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for NATESTO
Sponsor Trials
Other 9
Industry 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.